Alzheimer and Sleep

• Status: Completed
• Trial end date: 2013-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of the study is the analysis of two inhibitors of Ach-E: galantamine and donépézil in over 65 years' old patients suffering from Alzheimer disease (MMSE between 20 and 26) without Alzheimer's medication.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Clermont-Ferrand
• Collaborator: Janssen-Cilag Farmaceutica Ltda.
• Treatments: Donepezil; Galantamine

Criteria

Inclusion Criteria:

• 65 and over years old

• Patients suffering from Alzheimer disease

• Patient living with someone at home

• Written consent given

Exclusion Criteria:

• Galantamine or Donepezil hypersensibility

• Patient living alone and in a medicalized structure

• Concomitant medication

• Chronical diseases